|
| |
|
Program
Initiation & Due Diligence |
|
|
 We provide access to medicinal chemistry resources and
experience to pharmaceutical, biotech and venture companies in the
early stages of program
development.
We have assisted many clients in fund raising by preparing
medicinal chemistry development plans which outline critical program
milestones and decision points such as: hit criteria, primary and
secondary screening assays, and relevant animal efficacy models as
well as helping clients identify resources which are needed to
accomplish these tasks. Our reports and advice also provide overviews
of the relevant therapeutic areas and the associated patent landscape,
key compounds in discovery and development and strategies for hit
generation and lead progression.
Clients use these reports when presenting their projects
to potential funding and partnering groups. In addition, venture group
clients find these reports
helpful when
performing due diligence on potential new investment opportunities.
Areas we often address include:
-
Review of therapeutic areas and evaluation of key players
-
Identification of key compounds in discovery and
development
-
Identification of initial hits (from HTS or literature)
-
Design of strategies for hit explosion and lead
optimization
-
Identification of primary and secondary screening assays
-
Identification of relevant animal efficacy models
-
Identification of milestones and decision points.
|
|
